Vinay Shah's most recent trade in Adial Pharmaceuticals Inc was a trade of 40,000 Stock Option done . Disclosure was reported to the exchange on Nov. 16, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Adial Pharmaceuticals Inc | Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2024 | 40,000 | 40,000 | - | - | Stock Option | |
Virpax Pharmaceuticals Inc | Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 112,000 | 112,000 | - | - | Stock Option (right to buy) | |
Virpax Pharmaceuticals Inc | Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
Aravive Inc | Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to buy) | |
Aravive Inc | Vinay Shah | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 29 Jun 2021 | 1,000 | 190,842 (1%) | 0% | 5.3 | 5,310 | Common Stock |
Aravive Inc | Vinay Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 60,000 | 60,000 | - | - | Stock Options |